Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
Add more filters

Country/Region as subject
Publication year range
1.
Immunity ; 48(1): 107-119.e4, 2018 01 16.
Article in English | MEDLINE | ID: mdl-29329948

ABSTRACT

Natural killer (NK) cells are innate lymphoid cells, and their presence within human tumors correlates with better prognosis. However, the mechanisms by which NK cells control tumors in vivo are unclear. Here, we used reflectance confocal microscopy (RCM) imaging in humans and in mice to visualize tumor architecture in vivo. We demonstrated that signaling via the NK cell receptor NKp46 (human) and Ncr1 (mouse) induced interferon-γ (IFN-γ) secretion from intratumoral NK cells. NKp46- and Ncr1-mediated IFN-γ production led to the increased expression of the extracellular matrix protein fibronectin 1 (FN1) in the tumors, which altered primary tumor architecture and resulted in decreased metastases formation. Injection of IFN-γ into tumor-bearing mice or transgenic overexpression of Ncr1 in NK cells in mice resulted in decreased metastasis formation. Thus, we have defined a mechanism of NK cell-mediated control of metastases in vivo that may help develop NK cell-dependent cancer therapies.


Subject(s)
Antigens, Ly/metabolism , Fibronectins/metabolism , Interferon-gamma/metabolism , Killer Cells, Natural/metabolism , Natural Cytotoxicity Triggering Receptor 1/metabolism , Neoplasms/metabolism , Animals , Blotting, Western , Female , Flow Cytometry , Fluorescent Antibody Technique , Gene Expression Regulation, Neoplastic/genetics , Humans , Male , Mice , Microscopy, Confocal , Neoplasm Metastasis/genetics , Neoplasms/pathology , Real-Time Polymerase Chain Reaction , Signal Transduction/genetics
3.
Photodermatol Photoimmunol Photomed ; 37(5): 431-438, 2021 Sep.
Article in English | MEDLINE | ID: mdl-33738834

ABSTRACT

Solar urticaria is a well-recognized photodermatosis, sometimes accompanied by angioedema. However, isolated solar angioedema (ISA) is a rare and unrecognized entity. The purpose of our work was to systematically review the available data on ISA. Therefore, a systematic review of studies evaluating ISA was performed. Additionally, a case of a 21-years-old patient from our photodermatosis service is presented. The search yielded 421 publications, with 3 eligible for review. Together with our case, 5 cases were included overall. All patients were female. Four out of 5 patients first experienced ISA at childhood or early adulthood (age range 6-22 years). UVA photoprovocation was positive in the 3 out of the 4 patients who were tested. Improvement was noted following NB-UVB hardening (2 out of 5 patients) or a short course of oral prednisone (3 out of 5 patients) combined with regular sunscreen application. To conclude, ISA is an extremely rare entity, although it may be underdiagnosed due to lack of awareness. The clinician must consider ISA in the differential diagnosis of angioedema since it can have a detrimental effect on quality of life. Besides sun avoidance, there is no consensus regarding treatment.


Subject(s)
Angioedema , Photosensitivity Disorders , Urticaria , Adolescent , Adult , Angioedema/diagnosis , Angioedema/etiology , Child , Female , Humans , Photosensitivity Disorders/diagnosis , Photosensitivity Disorders/etiology , Quality of Life , Sunlight/adverse effects , Young Adult
4.
Dermatol Ther ; 33(6): e14329, 2020 11.
Article in English | MEDLINE | ID: mdl-32975350

ABSTRACT

Photodynamic therapy (PDT), traditionally used in patients with nonmelanoma skin cancer, has been found to be effective for various inflammatory skin conditions. Daylight-activated PDT (DL-PDT), in which the sun serves as the light source, is substantially less painful than conventional PDT. This study aimed to determine the safety and efficacy of DL-PDT in a series of patients with chronic hand eczema (CHE). A proof-of-concept prospective design was used. Eight patients diagnosed with CHE at a tertiary dermatology clinic underwent DL-PDT. The first treatment was administered at the clinic and subsequent treatments (up to four total) were self-administered at home at 2-week intervals. Outcome was evaluated with the Investigator Global Assessment (IGA; score 0-4), Dermatology Life Quality Index (DLQI; score 0-24), and blinded review of clinical photographs (graded on a quartile scale by percent improvement). There were six male and two female patients of mean age 35 years. All underwent at least three treatments. The IGA score improved by 2.5 points at 1 month, 2.7 at 3 months, and 2.2 at 6 months post-treatment, and the DLQI score improved by 7.9, 6.6, and 6.1 points, respectively. Clinical photograph grades improved by 2.9 points at 3 months. Side effects were mild and transient. All patients had some degree of recurrence after 6 months of treatment. The self-administered DL-PDT is easy to perform, moderately effective, and safe to use in patients with CHE. Repeated treatments might be required to maintain remission.


Subject(s)
Eczema , Keratosis, Actinic , Photochemotherapy , Adult , Aminolevulinic Acid/therapeutic use , Eczema/diagnosis , Eczema/drug therapy , Female , Humans , Keratosis, Actinic/drug therapy , Male , Neoplasm Recurrence, Local/drug therapy , Photosensitizing Agents/adverse effects , Prospective Studies
5.
Photodermatol Photoimmunol Photomed ; 35(1): 11-16, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30066408

ABSTRACT

BACKGROUND: Actinic cheilitis (AC) is a common, chronic premalignant condition resulting from protracted sun exposure affecting the vermilion border of the lower lip. Treatment of AC aims at terminating the progression to squamous cell carcinoma by obliterating the primary lesion, and includes ablative methods; nonablative modalities such as cryotherapy, electrodessication, chemical peeling, topical imiquimod and 5-fluorouracil; and photodynamic therapy (PDT). Daylight-activated PDT, in which natural daylight serves as the light source, showed promising results in the treatment of actinic keratoses with substantially less pain than conventional PDT. PURPOSE: To determine the safety and efficacy of daylight PDT in a series of patients with AC. METHODS: Eleven patients with AC were treated with daylight PDT. All patients underwent repeated treatment sessions until clinical and histological remission were achieved. RESULTS: Cure rate was 91% (10 of 11 patients, three females/eight males; mean age 59.2 ± 14.4 years). Mean number of treatments to attain cure was 2.7. Patients experienced mild erythema and minimal to no pain during treatment. CONCLUSIONS: Daylight PDT is a promising modality for the treatment of AC, with impressive cosmetic results and few side effects.


Subject(s)
Cheilitis/drug therapy , Light , Photochemotherapy , Adult , Aged , Female , Humans , Male , Middle Aged , Retrospective Studies
6.
Dermatology ; 233(5): 390-395, 2017.
Article in English | MEDLINE | ID: mdl-29212071

ABSTRACT

BACKGROUND: Telangiectasias are permanent dilations of blood capillaries which appear in a variety of medical conditions. Cutaneous palmar telangiectasias have been postulated to be associated with smoking. OBJECTIVE: To determine whether a significant correlation exists between palmar telangiectasias and smoking habits. PATIENTS AND METHODS: A total of 124 volunteers participated in this observational study by allowing physical evaluation of their palms and by completing a questionnaire. RESULTS: Palmar telangiectasias were found to be associated with current or past smoking. Neither age nor gender was found to be a co-contributor. DISCUSSION: Palmar telangiectasias were found to constitute highly specific and sensitive markers for prolonged smoking.


Subject(s)
Skin/blood supply , Smoking/adverse effects , Telangiectasis/etiology , Adult , Aged , Female , Hand , Humans , Male , Middle Aged , Risk Factors , Skin/pathology , Telangiectasis/diagnosis
7.
Lasers Med Sci ; 31(6): 1093-6, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27184154

ABSTRACT

Angiolymphoid hyperplasia with eosinophilia (ALHE) is an uncommon dermatosis of unknown etiology that manifests as characteristic red nodules and papules with a predilection for the scalp and periauricular region. Treatment is required for both esthetic and functional reasons, as lesions may ulcerate and bleed. Many treatment approaches have been reported, including excision, systemic medical approaches, topical or intralesional therapies, and non-invasive modalities including cryotherapy, electrosurgery, and laser. Treatments have exhibited variable efficacy, and the recurrence rate is 100 %. We report the combination of pulsed dye laser and CO2 laser in the treatment of ALHE in 14 patients. All patients exhibited clinical response after a mean of 2.4 ± 0.4 treatment sessions. The clinical efficacy of the combined treatment, together with its well-tolerated nature, render the use of pulsed dye laser in combination with CO2 laser, a viable treatment for debulking ALHE lesions. Ongoing maintenance treatments are needed to due to the high degree of relapse.


Subject(s)
Angiolymphoid Hyperplasia with Eosinophilia/rehabilitation , Lasers, Dye/therapeutic use , Lasers, Gas/therapeutic use , Adult , Angiolymphoid Hyperplasia with Eosinophilia/pathology , Combined Modality Therapy , Cryotherapy , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local
8.
Photodermatol Photoimmunol Photomed ; 31(6): 302-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26052871

ABSTRACT

BACKGROUND: Solar urticarial (SU) is characterized by erythema, whealing, and/or pruritus occurring minutes after sun exposure. Treatment is difficult and often unsatisfactory. OBJECTIVES: To determine the action spectra and minimal urticaria dose (MUD) and to tailor a treatment regimen graded according to disease severity in a series of patients with SU. PATIENTS AND METHODS: Eleven patients (seven females, four males, age range: 5-60 years) with a clinical history suggestive of SU, verified by photo-provocation tests to ultraviolet A (UVA), visible light, and/or UVB, were treated with various combinations of antihistamines and leukotriene receptor antagonist. RESULTS: All patients were sensitive to visible light (median MUD 50 J/cm(2)). Three patients were sensitive to UVA (median MUD 3.75 J/cm(2)), and one patient was sensitive to UVB (MUD of 0.03 J/cm(2)). Two patients experienced a spontaneous remission without treatment. One patient declined treatment. The remaining eight patients were managed by a combination of antihistamines (desloratidine, fexofenadine, cetirizine HCl) and a leukotriene receptor antagonist (montelukast). Seven of the 8 patients experienced a sustained remission of symptoms and signs following treatment. CONCLUSIONS: Photoprovocation for SU with determination of action spectra and MUD enables specifically tailored treatment regimens consisting of combinations of antihistamines and leukotriene receptor antagonist.


Subject(s)
Acetates/therapeutic use , Histamine H1 Antagonists, Non-Sedating/therapeutic use , Leukotriene Antagonists/therapeutic use , Photosensitivity Disorders/drug therapy , Quinolines/therapeutic use , Sunlight/adverse effects , Urticaria/drug therapy , Adolescent , Adult , Cetirizine/therapeutic use , Child , Child, Preschool , Cyclopropanes , Drug Therapy, Combination , Female , Humans , Loratadine/analogs & derivatives , Loratadine/therapeutic use , Male , Middle Aged , Photosensitivity Disorders/etiology , Remission Induction , Remission, Spontaneous , Severity of Illness Index , Sulfides , Terfenadine/analogs & derivatives , Terfenadine/therapeutic use , Ultraviolet Rays/adverse effects , Urticaria/etiology , Young Adult
10.
J Oral Maxillofac Surg ; 72(5): 927-34, 2014 May.
Article in English | MEDLINE | ID: mdl-24480757

ABSTRACT

The worldwide prevalence of leishmaniasis is increasing because of ecologic changes and increased medical profession awareness. Furthermore, solitary cases have been recently reported in Western countries. The authors describe the epidemiology, mode of transmission, and diagnosis of leishmaniasis and present 4 oral cases treated with systemic, localized, or combined therapy. The authors suggest that clinicians should maintain a high index of suspicion for atypical, resistant, oral and perioral lesions in individuals with a history of traveling in certain geographic regions. After diagnosis, treatment should be determined jointly by experts from the fields of oral and maxillofacial surgery, oral medicine, and dermatology based on leishmaniasis species and clinical presentation.


Subject(s)
Antiprotozoal Agents/therapeutic use , Leishmaniasis/diagnosis , Mouth Diseases/parasitology , Adolescent , Adult , Aged , Amphotericin B/therapeutic use , Animals , Antimony Sodium Gluconate/therapeutic use , Diagnosis, Differential , Endemic Diseases , Female , Humans , Leishmania braziliensis/isolation & purification , Leishmania infantum/isolation & purification , Leishmania major/isolation & purification , Leishmaniasis/drug therapy , Leishmaniasis, Cutaneous/diagnosis , Leishmaniasis, Cutaneous/drug therapy , Lip Diseases/drug therapy , Lip Diseases/parasitology , Male , Mouth Diseases/drug therapy , Young Adult
11.
Bioorg Med Chem ; 21(3): 660-7, 2013 Feb 01.
Article in English | MEDLINE | ID: mdl-23286963

ABSTRACT

Two focused libraries based on two types of compounds, that is, thiazolidinediones and dioxazaborocanes were designed. Structural resemblances can be found between thiazolidinediones and well-known furanone type quorum sensing (QS) inhibitors such as N-acylaminofuranones, and/or acyl-homoserine lactone signaling molecules, while dioxazaborocanes structurally resemble previously reported oxazaborolidine derivatives which antagonized autoinducer 2 (AI-2) binding to its receptor. Because of this, we hypothesized that these compounds could affect AI-2 QS in Vibrio harveyi. Although all compounds blocked QS, the thiazolidinediones were the most active AI-2 QS inhibitors, with EC(50) values in the low micromolar range. Their mechanism of inhibition was elucidated by measuring the effect on bioluminescence in a series of V. harveyi QS mutants and by DNA-binding assays with purified LuxR protein. The active compounds neither affected bioluminescence as such nor the production of AI-2. Instead, our results indicate that the thiazolidinediones blocked AI-2 QS in V. harveyi by decreasing the DNA-binding ability of LuxR. In addition, several dioxazaborocanes were found to block AI-2 QS by targeting LuxPQ.


Subject(s)
Anti-Bacterial Agents/pharmacology , Boron Compounds/pharmacology , Quorum Sensing/drug effects , Thiazolidinediones/pharmacology , Vibrio/drug effects , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Boron Compounds/chemical synthesis , Boron Compounds/chemistry , Dose-Response Relationship, Drug , Microbial Sensitivity Tests , Molecular Structure , Quorum Sensing/genetics , Structure-Activity Relationship , Thiazolidinediones/chemical synthesis , Thiazolidinediones/chemistry , Vibrio/growth & development
12.
Am J Hum Genet ; 85(2): 254-63, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19631308

ABSTRACT

Inherited disorders of elastic tissue represent a complex and heterogeneous group of diseases, characterized often by sagging skin and occasionally by life-threatening visceral complications. In the present study, we report on an autosomal-recessive disorder that we have termed MACS syndrome (macrocephaly, alopecia, cutis laxa, and scoliosis). The disorder was mapped to chromosome 20p11.21-p11.23, and a homozygous frameshift mutation in RIN2 was found to segregate with the disease phenotype in a large consanguineous kindred. The mutation identified results in decreased expression of RIN2, a ubiquitously expressed protein that interacts with Rab5 and is involved in the regulation of endocytic trafficking. RIN2 deficiency was found to be associated with paucity of dermal microfibrils and deficiency of fibulin-5, which may underlie the abnormal skin phenotype displayed by the patients.


Subject(s)
Alopecia/genetics , Cutis Laxa/genetics , Guanine Nucleotide Exchange Factors/deficiency , Scoliosis/genetics , Skull/growth & development , Adolescent , Adult , Carrier Proteins/genetics , Case-Control Studies , Chromosome Mapping , Chromosomes, Human, Pair 20 , Consanguinity , Cutis Laxa/metabolism , Dermatologic Surgical Procedures , Dermis/metabolism , Dermis/pathology , Elastic Tissue/metabolism , Elastic Tissue/ultrastructure , Extracellular Matrix Proteins/metabolism , Frameshift Mutation , Genes, Recessive , Guanine Nucleotide Exchange Factors/genetics , Homozygote , Humans , Immunohistochemistry , Phenotype , Radiography , Skin/metabolism , Skin/pathology , Skull/diagnostic imaging , Syndrome
13.
Photodermatol Photoimmunol Photomed ; 28(6): 332-4, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23126296

ABSTRACT

LED light sources for photodynamic therapy have become increasingly popular due to their narrow emission spectra that accurately match the absorption spectrum of porphyrins. Photodynamic therapy at low fluence rates has been shown to be as effective as high output irradiation for treatment of non-melanoma skin cancers. Fifteen patients with multiple non-hypertrophic actinic keratoses covering the scalp and the face were treated with aminolaevulinic acid photodynamic therapy using ordinary red LED traffic lamps as light source. All 15 patients improved clinically after one photodynamic therapy session. Only two patients required a second session to obtain satisfactory remission. Pain was minimal during these sessions. Red LED traffic lights constitute a simple alternative to far more complicated and expensive PDT light sources.


Subject(s)
Aminolevulinic Acid/administration & dosage , Keratosis, Actinic/therapy , Photochemotherapy/instrumentation , Photochemotherapy/methods , Photosensitizing Agents/administration & dosage , Aged , Female , Humans , Keratosis, Actinic/pathology , Male , Middle Aged
14.
EMBO Mol Med ; 14(8): e15653, 2022 08 08.
Article in English | MEDLINE | ID: mdl-35785521

ABSTRACT

Irradiation-induced alopecia and dermatitis (IRIAD) are two of the most visually recognized complications of radiotherapy, of which the molecular and cellular basis remains largely unclear. By combining scRNA-seq analysis of whole skin-derived irradiated cells with genetic ablation and molecular inhibition studies, we show that senescence-associated IL-6 and IL-1 signaling, together with IL-17 upregulation and CCR6+ -mediated immune cell migration, are crucial drivers of IRIAD. Bioinformatics analysis colocalized irradiation-induced IL-6 signaling with senescence pathway upregulation largely within epidermal hair follicles, basal keratinocytes, and dermal fibroblasts. Loss of cytokine signaling by genetic ablation in IL-6-/- or IL-1R-/- mice, or by molecular blockade, strongly ameliorated IRIAD, as did deficiency of CCL20/CCR6-mediated immune cell migration in CCR6-/- mice. Moreover, IL-6 deficiency strongly reduced IL-17, IL-22, CCL20, and CCR6 upregulation, whereas CCR6 deficiency reciprocally diminished IL-6, IL-17, CCL3, and MHC upregulation, suggesting that proximity-dependent cellular cross talk promotes IRIAD. Therapeutically, topical application of Janus kinase blockers or inhibition of T-cell activation by cyclosporine effectively reduced IRIAD, suggesting the potential of targeted approaches for the treatment of dermal side effects in radiotherapy patients.


Subject(s)
Radiodermatitis , Receptors, CCR6 , Animals , Interleukin-17/genetics , Interleukin-17/metabolism , Interleukin-6/genetics , Mice , Receptors, CCR6/genetics , Receptors, CCR6/metabolism , Transcriptome
16.
J Drugs Dermatol ; 7(11): 1033-7, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19110733

ABSTRACT

BACKGROUND: Basal cell carcinoma (BCC) is a common malignancy accounting for 80% of all nonmelanoma skin cancers. Mohs micrographic surgery (MMS) is considered superior to alternative treatments, but the procedure is time consuming and costly. Alternative simpler techniques to facilitate accurate tumor demarcation are therefore in demand. Fluorescence imaging following application of 5-aminolevulinic acid is a noninvasive diagnostic technique that gives rapid information about the superficial extent of the skin tumor. OBJECTIVE: To ascertain whether fluorescence imaging improves the clinical tumor border assessment by investigating the consistency between tumor size determination by MMS, clinical assessment, and fluorescence imaging. METHODS: Eighteen patients with histologically verified nodular BCCs on the face scheduled for MMS were included in the study. The night before the surgical procedure, 5-aminolevulinic methyl ester cream was applied to the lesion. The following morning, tumor borders were determined clinically (clinical size), after illumination with Wood's light (fluorescence size), and by the tumor defect left on the skin surface following removal of the MMS specimen (Mohs size). RESULTS: The median tumor sizes were 93.05 mm2 (Mohs size), 61.05 mm2 (clinical size), and 72.75 mm2 (fluorescence size). The interclass correlation coefficients between Mohs size and fluorescence size was 0.984 and Mohs size and clinical size was 0.752. CONCLUSION: Tumor border estimation by fluorescence imaging and clinical assessment underestimate the genuine tumor size determined by MMS; however, the fluorescence size showed a higher degree of consistency with the Mohs size than did the clinical size.


Subject(s)
Microscopy, Fluorescence , Neoplasms, Basal Cell/pathology , Skin Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Female , Fluorescent Dyes , Humans , Male , Middle Aged , Mohs Surgery , Neoplasms, Basal Cell/surgery , Skin Neoplasms/surgery , Surgical Procedures, Operative
18.
Int J Pharm ; 524(1-2): 290-303, 2017 May 30.
Article in English | MEDLINE | ID: mdl-28373103

ABSTRACT

The percutaneous passage of poorly skin absorbed molecules can be improved using nanocarriers, particularly biodegradable polymeric nanospheres (NSs) or nanocapsules (NCs). However, penetration of the encapsulated molecules may be affected by other factors than the nanocarrier properties. To gain insight information on the skin absorption of two fluorescent cargos, DiIC18(5) and coumarin-6 were incorporated in NSs or NCs and topically applied on various human and porcine skin samples. 3D imaging techniques suggest that NSs and NCs enhanced deep dermal penetration of both probes similarly, when applied on excised human skin irrespective of the nature of the cargo. However, when ex vivo pig skin was utilized, the cutaneous absorption of DiIC18(5) was more pronounced by means of PLGA NCs than NSs. In contrast, PLGA NSs noticeably improved the porcine skin penetration of coumarin-6, as compared to the NCs. Furthermore, the porcine skin results were reproducible when triplicated whereas from various human skin samples, as expected, the results were not sufficiently reproducible and large deviations were observed. The overall findings from this comprehensive comparison emphasize the potential of PLGA NCs or NSs to promote cutaneous bioavailability of encapsulated drugs, exhibiting different physicochemical properties but depending on the nature of the skin.


Subject(s)
Drug Carriers/chemistry , Fluorescent Dyes/metabolism , Nanocapsules/chemistry , Nanospheres/chemistry , Skin Absorption , Administration, Cutaneous , Animals , Carbocyanines/metabolism , Coumarins/metabolism , Humans , Skin , Swine
19.
Biomed Pharmacother ; 60(5): 233-7, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16765564

ABSTRACT

The objective of the present study was to study the role of reactive oxygen species (ROS) in UVB induced cyclobutane pyrimidine dimer (CPD) formation in human keratinocytes, and to examine the modulating activity of low molecular weight antioxidants. To demonstrate the involvement of ROS, we examined the protective capacity of alpha-tocopherol, tempamine, and diethyldithiocarbamate (DDC) on CPD formation in intact cells and naked DNA. HaCaT cells and naked DNA in water solution were irradiated with UVB in the presence of the antioxidants and CPD was determined by ELISA. We found that all three antioxidants provided protection against UVB induced CPD formation. The protection was observed in intact cells only and not in naked DNA. Since some of the tested antioxidants do not possess UV absorbing qualities, our findings suggest that in a cellular environment ROS play a role in CPD formation.


Subject(s)
Antioxidants/therapeutic use , Keratinocytes/radiation effects , Pyrimidine Dimers/metabolism , Antioxidants/pharmacology , Cell Line , DNA/biosynthesis , DNA/isolation & purification , Enzyme-Linked Immunosorbent Assay , Humans , Keratinocytes/drug effects , Keratinocytes/metabolism , Lipid Peroxidation/drug effects , Oxidants/pharmacology , Reactive Oxygen Species/metabolism , Ultraviolet Rays , Vitamin E/pharmacology
20.
Clin Dermatol ; 24(3): 176-80, 2006.
Article in English | MEDLINE | ID: mdl-16714198

ABSTRACT

Onchocerciasis results from infestation by the nematode Onchocerca volvulus and is characterized by troublesome itching, skin lesions, and eye manifestations. Although partially controlled by international mass prevention programs, onchocerciasis remains a major health hazard and is endemic in Africa, Arabia, and the Americas. Onchocerciasis is spread by bites from infested black flies, which transmit larvae that subsequently develop into adult filariae. Skin symptoms are commonly nonspecific and include severe pruritus, acute and chronic dermatitis, vitiligo-like hypopigmentation, and atrophy. Onchocercal ocular disease covers a large spectrum of manifestations, which in severe cases, may lead to blindness. Diagnosis is usually made by direct visualization of the larvae emerging from superficial skin biopsies, "skin snips." In some cases, the microfilariae can also be directly observed at the slit lamp when migrating into the anterior chamber of the eye. Ivermectin is, at present, the drug of choice for skin and ocular manifestations. Recent research using a chemotherapeutic approach that targets filarial Wolbachia symbionts in the treatment and control of onchocerciasis, however, suggests that 100 mg/d of doxycycline for 6 weeks might be effective in reducing the filarial load and preventing ocular symptoms.


Subject(s)
Onchocerciasis, Ocular , Humans , Onchocerciasis, Ocular/diagnosis , Onchocerciasis, Ocular/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL